Aquestive rugi bersih GAAP Q2 FY26 melebar jadi USD 22,9 juta; revenue naik 38% jadi USD 13,8 juta
Reuters2026/08/11 20:02- Aquestive Therapeutics membukukan revenue kuartal II 2026 naik 38% menjadi $13,8 juta.
- Rugi bersih GAAP melebar menjadi $22,9 juta; rugi per saham GAAP memburuk menjadi $0,18.
- Adjusted EBITDA loss non-GAAP menyempit menjadi $5,2 juta dari $9,3 juta pada kuartal II 2025.
- Kas dan setara kas per 30 Juni 2026 turun menjadi $98,5 juta.
- Untuk Anaphylm, studi human factors dan PK selesai; tetap menargetkan resubmisi NDA pada kuartal III 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
